Verified factor-similar pair

IVOO vs QVMS

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
84
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • QVMS has the higher backtested relative Sharpe (1.218 vs 0.995).
  • IVOO has the lower published fee (0.07% vs 0.15%).
  • IVOO is cheaper on dividend valuation (116 vs 131, where 100 is each fund's historical median).
  • QVMS has the stronger regression fit (adjusted R-squared 0.974 vs 0.952).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

IVOO

Vanguard S&P Mid-Cap 400 ETF
SMB
Adj. R2
0.952
Rel. Sharpe
0.995
Mkt beta
0.99
AUM
US$3.3B
MER
0.07%
Valuation
116

QVMS

Invesco S&P SmallCap 600 QVM Multi-factor ETF
SMB
Adj. R2
0.974
Rel. Sharpe
1.218
Mkt beta
0.98
AUM
US$217M
MER
0.15%
Valuation
131

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
IVOO
+0.49
|t|
+13.8
QVMS
+1.00
|t|
+20.2
diff -0.51
HML
IVOO
+0.18
|t|
+5.1
QVMS
+0.23
|t|
+4.4
diff -0.05
RMW
IVOO
+0.15
|t|
+3.8
QVMS
+0.19
|t|
+4.2
diff -0.04
CMA
IVOO
-0.01
|t|
-0.3
QVMS
+0.01
|t|
+0.1
diff -0.02
UMD
IVOO
+0.03
|t|
+1.0
QVMS
+0.07
|t|
+2.1
diff -0.05

Why This Pair Matches

Exposure level
80
Exposure shape
99
Mkt beta diff
0.01
Rel. Sharpe diff
0.224

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

IVOO fund page QVMS fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.